BHC

Bausch Health Companies Inc (BHC)

Healthcare • NYSE$5.75+0.35%

Key Fundamentals
Symbol
BHC
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Price
$5.75
Daily Change
+0.35%
Market Cap
$2.15B
Trailing P/E
N/A
Forward P/E
1.42
52W High
$8.69
52W Low
$4.41
Analyst Target
$7.57
Dividend Yield
N/A
Beta
0.42
About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health C

Company website

Research BHC on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...